Flavio Rizzolio

发表

Abstract LB-080: Reactivating RBL2/p130 oncosuppressive function as a new, possible antitumoral strategy

Francesca Pentimalli, Luca Esposito, Iris Maria Forte, 2015 .

Identification of New Fyn Kinase Inhibitors Using a FLAP-Based Approach

Flavio Rizzolio, Tiziano Tuccinardi, Adriano Martinelli, 2013, J. Chem. Inf. Model..

The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine

Tiziano Tuccinardi, Muhammad Adeel, Flavio Rizzolio, 2019, Molecules.

Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring.

Flavio Rizzolio, Giulia Moro, Ligia Maria Moretto, 2019, ChemistrySelect.

Pharmaco‐metabolomics: An emerging “omics” tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets

Flavio Rizzolio, Giuseppe Toffoli, A. Giordano, 2012, Journal of cellular physiology.

Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma.

Fabio Benedetti, Elena Pellizzoni, Flavio Rizzolio, 2016, Biosensors & bioelectronics.

Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer

Flavio Rizzolio, Martin Savard, Fernand Gobeil, 2018, Oncotarget.

Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects

Flavio Rizzolio, Tiziano Tuccinardi, Giulio Poli, 2019, Journal of cellular physiology.

An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer

Igor Jurisica, Chiara Pastrello, Flavio Rizzolio, 2015, Oncotarget.

Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models.

Flavio Rizzolio, Giuseppe Toffoli, Vincenzo Canzonieri, 2016, Nanomedicine.